open access

Vol 73, No 1 (2022)
Clinical vignette
Submitted: 2021-10-11
Accepted: 2021-10-24
Published online: 2022-02-14
Get Citation

Sequential therapies in gastric gastrinoma

Violetta Rosiek1
·
Pubmed: 35381105
·
Endokrynol Pol 2022;73(1):171-172.
Affiliations
  1. Department of Endocrinology and Neuroendocrine Tumours, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland

open access

Vol 73, No 1 (2022)
Clinical Vignette
Submitted: 2021-10-11
Accepted: 2021-10-24
Published online: 2022-02-14

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

gNEN; gastrinoma; somatostatin analogues; PRRT

About this article
Title

Sequential therapies in gastric gastrinoma

Journal

Endokrynologia Polska

Issue

Vol 73, No 1 (2022)

Article type

Clinical vignette

Pages

171-172

Published online

2022-02-14

Page views

5353

Article views/downloads

417

DOI

10.5603/EP.a2021.0101

Pubmed

35381105

Bibliographic record

Endokrynol Pol 2022;73(1):171-172.

Keywords

gNEN
gastrinoma
somatostatin analogues
PRRT

Authors

Violetta Rosiek

References (5)
  1. Okamoto T, Yoshimoto T, Ohike N, et al. Spontaneous regression of gastric gastrinoma after resection of metastases to the lesser omentum: A case report and review of literature. World J Gastroenterol. 2021; 27(1): 129–142.
  2. Rossi RE, Elvevi A, Citterio D, et al. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies. World J Gastroenterol. 2021; 27(35): 5890–5907.
  3. Cingam SR, Botejue M, Hoilat GJ. Gastrinoma. StatPearls, Treasure Island 2021.
  4. Lipiński M, Rydzewska G, Foltyn W, et al. Nowotwory neuroendokrynne żołądka i dwunastnicy z uwzględnieniem gastrinoma (zasady postępowania rekomendowane przez Polską Sieć Guzów Neuroendokrynnych). Endokrynol Pol. 2017; 68(2): 138–153.
  5. Pavel M, Öberg K, Falconi M, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(7): 844–860.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl